Advertisement

Topics

 Taro Pharmaceutical Industries Ltd. Company Profile

10:45 EST 13th November 2018 | BioPortfolio


News Articles [584 Associated News Articles listed on BioPortfolio]

Taro to Announce First Quarter Results on August 9, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on T...

Kal Sundaram appointed as chairman of Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd. (Taro) announced that Dilip Shanghvi has resigned, effective April 18, as chairman and a member of Taro's board of directors in order to focus on other growth prior...

Taro Annual Report on Form 20-F Available

For Fiscal Year Ended March 31, 2018 Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March ...

Taro Terminates Agreement with NovaBiotics

License agreement for anti-fungal peptide treatment, Novexatin® Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that it has ...

Taro Pharmaceutical Industries Ltd (TARO) CEO Uday Baldota on 2018/19 First Half Results - Earnings Call Transcript

Taro to Announce Full Year Results on May 17, 2018

Earnings Call to Discuss Results to be Conducted Friday, May 18 at 8:00 am EDT Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release ...

Taro to Announce Second Quarter Results on November 5, 2018

Earnings Call to be Conducted Tuesday, November 6 at 8:00 am EST Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results...

Taro Pharmaceutical's (TARO) CEO Uday Baldota on Q4 2018 Results - Earnings Call Transcript

Drugs and Medications [739 Associated Drugs and Medications listed on BioPortfolio]

Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]

Children's Cetirizine Hydrochloride Oral Solution

Lithium carbonate [Sun Pharmaceutical Industries Limited ]

Lithium Carbonate Tablets USP

Epinastine hydrochloride [Sun Pharmaceutical Industries Limited ]

Epinastine Hydrochloride Ophthalmic Solution 0.05%Sterile

Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]

Cetirizine Hydrochloride Oral Solution

Dawnmist hypoallergenic petroleum [Donovan Industries, Inc.]

DawnMist Hypoallergenic Petroleum Jelly

PubMed Articles [628 Associated PubMed Articles listed on BioPortfolio]

Taro starch (Colocasia esculenta) and citric acid modified taro starch as tablet disintegrating agents.

The objective of the present work is to study the physicochemical and functional properties of taro starch (Colocasia esculenta) and to further modify the starch by treating with citric acid to obtain...

Conserving and Sharing Taro Genetic Resources for the Benefit of Global Taro Cultivation: A Core Contribution of the Centre for Pacific Crops and Trees.

This review article gives an account of the origin, domestication, and dispersal of taro, a staple food crop in many countries in the humid tropics and subtropics. Genetic diversity studies indicated ...

Literary evidence for taro in the ancient Mediterranean: A chronology of names and uses in a multilingual world.

Taro, Colocasia esculenta (L.) Schott, is a vegetable and starchy root crop cultivated in Asia, Oceania, the Americas, Africa, and the Mediterranean. Very little is known about its early history in th...

Adsorption of Cu (II) and Ni (II) from aqueous solutions by taro stalks chemically modified with diethylenetriamine.

Taro stalks (TS) were modified by diethylenetriamine (DETA) to obtain the modified taro stalks adsorbents (recorded as MTSA). This kind of raw material is unprecedented and the method of modification ...

Physical stabilities of taro starch nanoparticles stabilized Pickering emulsions and the potential application of encapsulated tea polyphenols.

In this research, Pickering emulsion stabilized by taro starch nanoparticles was successfully prepared, and the potential application of encapsulating tea polyphenols was investigated. The nanoparticl...

Clinical Trials [352 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

A Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...

Companies [2214 Associated Companies listed on BioPortfolio]

 Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...

Taro Pharmaceutical Ind.

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...

Taro Pharmaceuticals U.S.A., Inc.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...

Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...

More Information about " Taro Pharmaceutical Industries Ltd." on BioPortfolio

We have published hundreds of  Taro Pharmaceutical Industries Ltd. news stories on BioPortfolio along with dozens of  Taro Pharmaceutical Industries Ltd. Clinical Trials and PubMed Articles about  Taro Pharmaceutical Industries Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of  Taro Pharmaceutical Industries Ltd. Companies in our database. You can also find out about relevant  Taro Pharmaceutical Industries Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record